Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
PALONOSETRON HYDROCHLORIDE
Fresenius Kabi Limited
A04AA05
PALONOSETRON HYDROCHLORIDE
250 Microgram
Solution for Injection
Product subject to prescription which may not be renewed (A)
Serotonin (5ht3) antagonists
Authorised
2016-10-28
PACKAGE LEAFLET: INFORMATION FOR THE USER PALONOSETRON 250 MICROGRAMS SOLUTION FOR INJECTION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. THE NAME OF YOUR MEDICINE IS PALONOSETRON 250 MICROGRAMS SOLUTION FOR INJECTION; IN THE REST OF THE LEAFLET IT WILL BE CALLED “PALONOSETRON”. WHAT IS IN THIS LEAFLET 1. What Palonosetron is and what it is used for 2. What you need to know before you use Palonosteron 3. How to use Palonosteron 4. Possible side effects 5. How to store Palonosteron 6. Contents of the pack and other information 1. WHAT PALONOSETRON IS AND WHAT IT IS USED FOR Palonosetron belongs to a group of medicines known as serotonin (5HT 3 ) antagonists. These have the ability to block the action of the chemical serotonin, which can cause nausea and vomiting. Palonosetron is used for the prevention of nausea and vomiting associated with cancer chemotherapy in adults, adolescents and children over one month of age. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE PALONOSETRON DO NOT USE PALONOSETRON: - if you are allergic to palonosetron or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before using Palonosetron: - If you have acute bowel obstruction or a history of repeat Прочитать полный документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Palonosetron 250 micrograms solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 50 micrograms palonosetron (as hydrochloride). Each vial of 5 ml of solution contains 250 micrograms palonosetron (as hydrochloride). Excipient with known effect This medicinal product contains 0.04 mmol (or 0.91 mg) sodium per ml. Maximum dose for children contains 1.19 mmol (or 27.3 mg) sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection Clear, colourless solution, free from visible particles. pH 4.7 – 5.3 Osmolality 270 – 330 mOsmol/kg 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Palonosetron is indicated in adults for: • the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, • the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. Palonosetron is indicated in paediatric patients 1 month of age and older for: • the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Palonosetron should be used only before chemotherapy administration. This medicinal product should be administered by a healthcare professional under appropriate medical supervision. Posology _Adults_ 250 micrograms palonosetron administered as a single intravenous bolus approximately 30 minutes before the start of chemotherapy. Palonosetron should be injected over 30 seconds. The efficacy of Palonosetron in the prevention of nausea and vomiting induced by highly emetogenic chemotherapy may be enhanced by the addition Прочитать полный документ